Use Code: WF26 And Get 30% OFF, T&C Applay | Get Free Delivery With No Minimum Order

Use Code: WF26 And Get 30% OFF, T&C Applay | Get Free Delivery With No Minimum Order

Hotline :   920008144 Download app now
Magazine
Enjoy free Shipping 🚚 ‎ ‎ ‎ ‎ ‎ ‎Shop from over 12000 products 🔥 ‎ ‎ ‎ ‎ ‎ ‎Fast Delivery 🚀
Almujtama Pharmacy logo
EZOLVIN 8/MG TAB 20/TAB
EZOLVIN 8/MG TAB 20/TAB
8.85
EZOLVIN 8/MG TAB 20/TAB

Frequently bought together

⁨WF26⁩
Brand : EZOLVIN

EZOLVIN 8/MG TAB 20/TAB

8.85
  • Sku : I-002067
  • Key features

    EZOLVIN 8 mg tablets contain the mucolytic active ingredient bromhexine (8 mg per tablet). Bromhexine reduces sputum viscosity by altering mucopolysaccharide/mucoprotein structure and increases serous bronchial secretions to enhance mucociliary clearance and expectoration. It is indicated for symptomatic relief of productive cough and chest congestion in acute and chronic respiratory conditions with thick or viscous mucus, including acute or chronic bronchitis, tracheobronchitis, COPD and bronchiectasis. Available OTC as 8 mg tablets, packed 20 tablets per pack.

     

    • Brand: EZOLVIN
    • Active Ingredient: BROMHEXINE 8mg
    • Strength: 8mg
    • Dosage Form: Tablet
    • Pack Size: 20 Tablets
    • Route: Oral use
    • Prescription Status: OTC
    • Therapeutic Class: Respiratory
    • Pharmacological Group: Cough & Cold Preparations
    • Drug Class: Mucolytic (secretolytic/expectorant).
    • Manufacturer: KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES
    • Country of Origin: Kuwait
    • SFDA Registration No.: 2204257271
    • Shelf Life: 48 months
    • Storage: store below 25°c
    • Symptom Target: Cough
    • Sedating: No

Frequently bought together

Description
Specification

Indications

Approved Uses

Symptomatic treatment of productive cough and chest congestion in acute and chronic respiratory conditions associated with thick/viscous mucus (e.g., acute/chronic bronchitis, tracheobronchitis, COPD/bronchiectasis with mucus hypersecretion).

Off-Label Uses

No widely accepted off-label uses for the oral tablet in routine practice; use is primarily for mucus-related productive cough conditions.

Dosage & Administration

Initial Dose

8mg three times daily (adults)

Maintenance Dose

8mg three times daily (adults)

Maximum Dose

Adults: up to 48 mg/day (e.g., 8-16 mg three times daily; maximum 16 mg TID).

Dose Adjustment Notes

Use with caution in patients with severe hepatic or renal impairment as clearance may be reduced.

Side Effects

Common Side Effects

Gastrointestinal upset (nausea, vomiting, diarrhea, abdominal/epigastric pain), headache, dizziness; hypersensitivity reactions such as rash/urticaria can occur (rarely severe cutaneous reactions).

Side Effect Frequency

Common (≥1/1000 to <1/100): nausea, vomiting, diarrhea, upper abdominal pain. Uncommon: headache, dizziness, rash, urticaria. Rare: hypersensitivity reactions.

Safety & Warnings

Contraindications

Known hypersensitivity to bromhexine or to any excipients.

Driving Warning

No drowsiness warning; bromhexine is not sedating and does not impair driving ability.

Storage & Patient Advice

Stopping the Medicine

Safe to stop anytime if symptoms resolve. Do not use for more than 14 days without medical advice.

Pharmacology

Mechanism of Action

Bromhexine is a mucolytic/secretolytic that reduces sputum viscosity by altering mucopolysaccharide/mucoprotein structure and increases serous bronchial secretions, improving mucociliary clearance and expectoration.

Bioavailability

Oral systemic bioavailability is approximately 22-27% due to extensive first-pass metabolism (75-80%) despite rapid gastrointestinal absorption.

Excretion

Primarily renal (about 85-90%) as metabolites.

Product Information

Composition per Dose

Each tablet: 8mg bromhexine hydrochloride

Generic Availability

Yes

OTC Alternatives

Guaifenesin (expectorant) and acetylcysteine (mucolytic).

Symptom Target

Cough

Sedating

No

 

Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 25-05-2026

Similar Products

whatsapp